End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% | -.--% | -45.40% |
Jun. 06 | Hainan Poly Pharm's Unit Gets Nod to Market Raw Drug Ingredient Gadoterate Gluconamide | MT |
May. 14 | China Grants Registration Approval for Antibacterial Drug | MT |
Performance
1 day | -18.75% | ||
3 months | -33.67% | ||
6 months | -45.52% | ||
Current year | -45.40% | ||
1 year | -39.43% | ||
3 years | -75.90% | ||
5 years | -59.31% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-18.75% | -.--% | -45.40% | -39.43% | 764M | ||
+1.52% | +3.61% | +45.82% | +90.56% | 765B | ||
+0.45% | +0.28% | -6.16% | -8.08% | 354B | ||
+0.11% | +4.09% | +19.86% | +18.03% | 331B | ||
+0.50% | +5.07% | +9.32% | +22.61% | 299B | ||
+0.41% | +2.06% | +18.87% | +6.51% | 248B | ||
-0.76% | +3.53% | -1.72% | -14.19% | 219B | ||
-0.55% | +1.66% | +11.08% | +3.78% | 216B | ||
-0.22% | -0.27% | +5.90% | +39.43% | 164B | ||
-0.76% | -0.28% | -0.73% | -26.66% | 162B | ||
-1.35% | -0.20% | +0.19% | -5.36% | 123B | ||
-0.18% | +1.55% | +11.90% | +18.12% | 84.52B | ||
+1.47% | +0.95% | -19.16% | -35.99% | 84.08B | ||
+1.35% | +0.67% | -20.13% | -17.18% | 80.61B | ||
-0.70% | +6.22% | +49.48% | +13.25% | 71.16B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | -1.26% | +0.55% | +5.27% | +4.36% | ||
Weighted average by Cap. | +0.04% | +2.43% | +15.95% | +24.36% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -45.40% | ||
2023 | -8.27% | ||
2022 | -55.20% | ||
2021 | +31.39% | ||
2020 | +13.32% | ||
2019 | +92.83% | ||
2018 | -13.68% | ||
2017 | +362.60% |
- Stock Market
- Equities
- 300630 Stock
- Quotes Hainan Poly Pharm. Co., Ltd